Gregoire  Ramade net worth and biography

Gregoire Ramade Biography and Net Worth

SVP of Vapotherm
Gregoire Ramade joined Vapotherm in May 2016 as Vice President, International and was promoted to Senior Vice President and Chief Commercial Officer in September 2020. Before joining Vapotherm, Mr. Ramade worked at Becton Dickinson Medical-Pharmaceutical Systems as Vice President of Global Marketing and Business Development from January 2013 to May 2016. He also held the positions of Senior Marketing Director Home Healthcare Solution at Philips Healthcare from 2010 to 2012, Marketing Director EMEA at Philips Respironics from 2005 to 2009 and Product Manager of Consumable Masks and Accessories at Philips Respironics from 2004 to 2005. Mr. Ramade holds a bachelor’s degree in International Business with a minor in Economics from the American University of Paris and an MBA in International Business and Marketing from the Ecole Nationale des Ponts et Chausses School of International Management.

What is Gregoire Ramade's net worth?

The estimated net worth of Gregoire Ramade is at least $3,577.72 as of March 22nd, 2021. Mr. Ramade owns 2,826 shares of Vapotherm stock worth more than $3,578 as of April 25th. This net worth evaluation does not reflect any other investments that Mr. Ramade may own. Learn More about Gregoire Ramade's net worth.

How do I contact Gregoire Ramade?

The corporate mailing address for Mr. Ramade and other Vapotherm executives is 100 DOMAIN DRIVE, EXETER NH, 03833. Vapotherm can also be reached via phone at (866) 410-9986 and via email at [email protected]. Learn More on Gregoire Ramade's contact information.

Has Gregoire Ramade been buying or selling shares of Vapotherm?

Gregoire Ramade has not been actively trading shares of Vapotherm within the last three months. Most recently, Gregoire Ramade sold 250 shares of the business's stock in a transaction on Thursday, November 4th. The shares were sold at an average price of $200.24, for a transaction totalling $50,060.00. Learn More on Gregoire Ramade's trading history.

Who are Vapotherm's active insiders?

Vapotherm's insider roster includes Joel Dube (CAO), John Landry (CFO), James Liken (Director), Gregoire Ramade (SVP), and Thomas Smith (Insider). Learn More on Vapotherm's active insiders.

Are insiders buying or selling shares of Vapotherm?

In the last twelve months, Vapotherm insiders bought shares 6 times. They purchased a total of 79,234 shares worth more than $262,952.54. The most recent insider tranaction occured on September, 7th when CEO Joseph Army bought 21,987 shares worth more than $72,776.97. Insiders at Vapotherm own 15.8% of the company. Learn More about insider trades at Vapotherm.

Information on this page was last updated on 9/7/2023.

Gregoire Ramade Insider Trading History at Vapotherm

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/4/2021Sell250$200.24$50,060.00View SEC Filing Icon  
9/21/2021Sell250$219.84$54,960.00View SEC Filing Icon  
8/20/2021Sell250$202.48$50,620.00View SEC Filing Icon  
7/28/2021Sell1,000$200.00$200,000.00View SEC Filing Icon  
3/22/2021Sell250$206.56$51,640.002,826View SEC Filing Icon  
2/22/2021Sell250$223.28$55,820.00
1/20/2021Sell250$255.36$63,840.002,826View SEC Filing Icon  
12/21/2020Sell250$221.20$55,300.00
11/20/2020Sell250$207.36$51,840.00
10/20/2020Sell250$244.96$61,240.001,889View SEC Filing Icon  
9/21/2020Sell250$221.92$55,480.001,889View SEC Filing Icon  
8/20/2020Sell250$237.20$59,300.00
7/20/2020Sell250$394.40$98,600.001,589View SEC Filing Icon  
See Full Table

Gregoire Ramade Buying and Selling Activity at Vapotherm

This chart shows Gregoire Ramade's buying and selling at Vapotherm by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Vapotherm Company Overview

Vapotherm logo
Vapotherm, Inc., a medical technology company, focuses on the development and commercialization of proprietary high velocity therapy products used to treat patients of various ages suffering from respiratory distress in the United States and internationally. The company offers High Velocity Therapy systems, such as HVT 2.0, Precision Flow Hi-VNI, Precision Flow Plus, and Precision Flow Classic which delivers non-invasive ventilatory support to patients by providing heated, humidified, and oxygenated air at a high velocity to treat patients through a small-bore nasal interface. It also provides companion products, including Vapotherm Transfer Unit, which allows patients to be transferred between care areas within the hospital or ambulate while on therapy; Q50 compressor that provides compressed air necessary to run the precision flow systems in areas of the hospital without access to a wall gas source; aerosol aeroneb adaptor to facilitate delivery of aerosolized solutions; aerosol disposable patient circuit that is designed to streamline the provision of continuous and intermittent delivery of aerosol solutions for patients; and tracheostomy adaptors that simplifies the connection of the High Velocity Therapy systems to a tracheostomy collar used to wean patients off mechanical ventilation. In addition, the company offers ProSoft cannula to provide gentle contact with the skin; and disposable products comprising single-use disposables and nasal interfaces, as well as Oxygen Assist Module, which helps clinicians maintain oxygen levels within a target range. Vapotherm, Inc. was founded in 1993 and is headquartered in Exeter, New Hampshire.
Read More

Today's Range

Now: $1.27
Low: $1.27
High: $1.27

50 Day Range

MA: $1.25
Low: $0.92
High: $1.60

2 Week Range

Now: $1.27
Low: $0.75
High: $7.44

Volume

690 shs

Average Volume

4,455 shs

Market Capitalization

$7.86 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A